The 55 references in paper G. Toropina G., I. Uspenskaya A., N. Polonskaya N., N. Yakhno N., O. Voskresenskaya N., Zh. Glozman M., Г. Торопина Г., Ж. Глозман М., И. Успенская А., Н. Полонская Н., Н. Яхно Н., О. Воскресенская Н. (2015) “ЛИМБИЧЕСКИЙ ЭНЦЕФАЛИТ. ОБЗОР ЛИТЕРАТУРЫ И КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ // LIMBIC ENCEPHALITIS. LITERATURE REVIEW AND CASE REPORTS” / spz:neicon:nevro:y:2013:i:3:p:11-21

1
Ahern G.L., O’Connor M., Dalmau J. et al. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology. 1994; 44: 1270—4.
(check this in PDF content)
2
Amir J., Galbraith R.C. Paraneoplastic limbic encephalopathy as a nonmetastatic complication of small cell lung cancer. South. Med. J. 1992; 85: 1013—4.
(check this in PDF content)
3
Anderson N.E., Barber P.A. Limbic encephalitis — a review. J. Clin. Neurosci. 2008; 15: 961—71.
(check this in PDF content)
4
Armangue T., Petit-Pedrol M., Dalmau J. Autoimmune encephalitis in children. J. Child Neurol. 2012; 27: 1460—9.
(check this in PDF content)
5
Bak T.H., Antoun N., Balan K.K., Hodges J.R. Memory lost, memory regained: neuropsychological fi ndings and neuroimaging in two cases of paraneoplastic limbic encephalitis with radically different outcomes. J. Neurol. Neurosurg. Psychiatry. 2001; 71: 40—7.
(check this in PDF content)
6
Bakheit A.M., Kennedy P.G., Behan P.O. Paraneoplastic limbic encephalitis: clinico-pathological correlations. J. Neurol. Neurosurg. Psychiatry. 1990; 53: 1084—8.
(check this in PDF content)
7
Bataller L., Kleopa K.A., Wu G.F. et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J. Neurol. Neurosurg. Psychiatry. 2007; 78: 381—5.
(check this in PDF content)
8
Bell B.B., Tognoni P.G., Bihrle R. Limbic encephalitis as a paraneoplastic manifestation of renal cell carcinoma. J. Urol. 1998; 160: 828.
(check this in PDF content)
9
Boronat A., Sabater L., Saiz A. et al. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011; 76: 795—800.
(check this in PDF content)
10
Brennan L.V., Craddock P.R. Limbic encephalopathy as a nonmetastatic complication of oat cell lung cancer. Its reversal after treatment of the primary lung lesion. Am. J. Med. 1983; 75: 518—20.
(check this in PDF content)
11
Brierley J.B., Corsellis J.A.N., Hierons R., Nevin S. Subacute encephalitis of later adult life. Mainly affecting the limbic area. Brain. 1960; 83: 357—68.
(check this in PDF content)
12
Buckley C., Oger J., Clover L. et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann. Neurol. 2001; 50: 73—8.
(check this in PDF content)
13
Burton G.V., Bullard D.E., Walther P.J., Burger P.C. Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer. 1988; 62: 2248—51.
(check this in PDF content)
14
Carr I. The Ophelia syndrome: memory loss in Hodgkin’s disease. Lancet. 1982; 1: 844—5.
(check this in PDF content)
15
Charatan F.B., Brierley J.B. Mental disorder associated with primary lung carcinoma. Br. Med. J. 1956; 1: 765—8.
(check this in PDF content)
16
Chitravas N., Jung R.C., Kofskey D.M. et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann. Neurol. 2011; 70: 437—44.
(check this in PDF content)
17
Corsellis J.A., Goldberg G.J., Norton A.R. «Limbic encephalitis» and its association with carcinoma. Brain. 1968; 91: 481—96.
(check this in PDF content)
18
Cunningham J.D., Burt M.E. Limbic encephalitis secondary to malignant thymoma. Ann. Thorac Surg. 1994; 58: 250—1.
(check this in PDF content)
19
Dalmau J., Graus F., Villarejo A. et al. Clinical analysis of antiMa2-associated encephalitis. Brain. 2004; 127: 1831—44.
(check this in PDF content)
20
Dalmau J., Bataller L. Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classifi cation with therapeutic implications. Neurology. 2007; 22: 526—37.
(check this in PDF content)
21
Dalmau J., Tuzun E., Wu H.Y. et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007; 61: 25—36.
(check this in PDF content)
22
Dalmau J., Lancaster E., Martinez-Hemandez E. et al. Clinical experience and laboratory investigations in patients with antiNMDAR encephalitis. Lancet Neurol. 2011; 10: 63—74.
(check this in PDF content)
23
Hollander A.M., van Hulst A.M., Meerwaldt J.D., Haasjes J.G. Limbic encephalitis. A rare presentation of the small-cell lung carcinoma. Gen. Hosp. Psychiatry. 1989; 11: 388—92.
(check this in PDF content)
24
Derouich I., Messouak O., Belahsen M.F. Syphilitic limbic encephalitis revealed by status epilepticus. BMJ Case Rep. 2013; Feb. 6 published online before print.
(check this in PDF content)
25
Derry C.P., Wilkie M.D., Al-Shahi Salman R., Davenport R.J. Autoimmune limbic encephalitis. Clin. Med. 2011; 11: 476—8.
(check this in PDF content)
26
Finke C., Kopp U.A., Prüss H. et al. Cognitive defi cits following anti-NMDA receptor encephalitis. J. Neurol. Neurosurg. Psychiatry. 2012; 83: 195—8.
(check this in PDF content)
27
Florance N.R., Davis R.L., Lam C. et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol. 2009; 66: 11—8.
(check this in PDF content)
28
Gast H., Schindler K., Z’graggen W.J., Hess C.W. Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy. Epilepsy Behav. 2010; 17: 555—7.
(check this in PDF content)
29
Graus F., Keime-Guibert F., Reñé R. et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001; 124: 1138—48.
(check this in PDF content)
30
Graus F., Saiz A., Lai M. et al. Neuronal surface antigen antibodies in limbic encephalitis. Clinical—immunologic associations. Neurology. 2008; 71: 930—6.
(check this in PDF content)
31
Gultekin S.H., Rosenfeld M.R., Voltz R. et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological fi ndings and tumour association in 50 patients. Brain. 2000; 123: 1481—94.
(check this in PDF content)
32
Haberlandt E., Bast T., Ebner A. et al. Limbic encephalitis in children and adolescent. Arch. Dis. Child. 2011; 96: 186—91.
(check this in PDF content)
33
Iizuka T., Sakai F., Ide T. et al. Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal. Neurology. 2008; 70: 504—11.
(check this in PDF content)
34
Irani S.R., Bera K., Waters P. et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010; 133: 1655—67.
(check this in PDF content)
35
Irani S.R., Alexander S., Waters P. et al. Antibodies to KV1 potassium channel-complex proteins (LGI1 and CASPR2) in limbic encephalitis, Morvan syndrome and acquired neuromyotonia. Brain. 2010; 133: 2724—48.
(check this in PDF content)
36
Kano O., Arasaki K., Ikeda K. et al. Limbic encephalitis associated with systemic lupus erythematosus. Lupus. 2009; 18: 1316—9.
(check this in PDF content)
37
Lancaster E., Martinez-Hernandez E., Titulaer M.J. et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011; 77: 1698—701.
(check this in PDF content)
38
Malter M.P., Helmstaedter C., Urbach H. et al. Antibodies to glutamic acid decarboxylase defi ne a form of limbic encephalitis. Ann. Neurol. 2010; 67: 470—8.
(check this in PDF content)
39
McArdle J.P., Millingen K.S. Limbic encephalitis associated with malignant thymoma. Pathology. 1988; 20: 292—5.
(check this in PDF content)
40
Rosenfeld M.R., Dalmau J. Cancer and the nervous system. Paraneoplastic disorders. In: Bradley W.G., Daroff R.B., Fenichel G.M., Jankovic J., eds. Neurology in clinical practice. 5th ed. Butterworth-Heinemann, Elsevier; 2008: 1405—15.
(check this in PDF content)
41
Rosenfeld M.R., Titulaer M.J., Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis. Five new things. Neurol. Clin. Pract. 2012; 2: 215—23.
(check this in PDF content)
42
Rueff L., Graber J.J., Bernbaum M., Kuzniecky R.I. Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations. Rev. Neurol. Dis. 2008; 5: 65—72.
(check this in PDF content)
43
Samarasekera S.R., Vincent A., Welch J.L. et al. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J. Neurol. Neurosurg. Psychiatry. 2007; 78: 391—4.
(check this in PDF content)
44
Schmitt S.E., Pargeon K., Frechette E.S. et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012; 79: 1094—100.
(check this in PDF content)
45
Schott J.M. Limbic encephalitis: A clinician’s guide. Pract. Neurol. 2006; 6: 143—53.
(check this in PDF content)
46
Serratrice G., Pellissier J., Serratrice J., De Paula A. Limbic encephalitis. Evolving concepts. Bull. Acad. Nat. de M@edecine. 2008; 192: 1531—42.
(check this in PDF content)
47
Stern R.C., Hulette C.M. Paraneoplastic limbic encephalitis associated with small cell carcinoma of the prostate. Mod. Pathol. 1999; 12: 814—8.
(check this in PDF content)
48
Stübgen J.P. Nervous system lupus mimics limbic encephalitis. Lupus. 1998; 7: 557—60.
(check this in PDF content)
49
Tan K.M., Lennon V.A., Klein C.J. et al. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008; 70: 1883—90.
(check this in PDF content)
50
Thieben M.J., Lennon V.A., Boeve B.F. et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004; 62: 1177—82.
(check this in PDF content)
51
Tsukamoto T., Mochizuki R., Mochizuki H. et al. Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon. J. Neurol. Neurosurg. Psychiatry. 1993; 56: 713—6.
(check this in PDF content)
52
Tüzün E., Dalmau J. Limbic encephalitis and variants: classifi cation, diagnosis and treatment. Neurologist. 2007; 13: 261—71.
(check this in PDF content)
53
Vincent A., Buckley C., Schott J.M. et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004; 127: 701—12.
(check this in PDF content)
54
Voltz R. Neuropsychological symptoms in paraneoplastic disorders. J. Neurol. 2007; 254 (Suppl. 2): 1184—6.
(check this in PDF content)
55
Wingfi eld T., Mchugh C., Vas A. et al. Autoimmune encephalitis: a case series and comprehensive review of the literature. Quart. J. Med. 2011; 104: 921—31.
(check this in PDF content)